Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma

@article{McCarten2019ImagingFD,
  title={Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma},
  author={K. McCarten and H. Nadel and B. Shulkin and S. Cho},
  journal={Pediatric Radiology},
  year={2019},
  volume={49},
  pages={1545 - 1564}
}
  • K. McCarten, H. Nadel, +1 author S. Cho
  • Published 2019
  • Medicine
  • Pediatric Radiology
  • Hodgkin lymphoma and non-Hodgkin lymphoma are common malignancies in children and are now highly treatable. Imaging plays a major role in diagnosis, staging and response using conventional CT and MRI and metabolic imaging with positron emission tomography (PET)/CT and PET/MRI. Cross-sectional imaging has replaced staging laparotomy and splenectomy by demonstrating abdominal nodal groups and organ involvement. [F-18]2-fluoro-2-deoxyglucose (FDG) PET provides information on bone marrow… CONTINUE READING
    4 Citations

    References

    SHOWING 1-10 OF 59 REFERENCES
    [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
    • 86
    Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
    • B. Cheson, R. Fisher, +4 authors T. Lister
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2014
    • 1,717
    • PDF
    Extranodal Hodgkin disease: spectrum of disease.
    • A. Guermazi, P. Brice, +4 authors J. Frija
    • Medicine
    • Radiographics : a review publication of the Radiological Society of North America, Inc
    • 2001
    • 229
    Revised International Pediatric Non-Hodgkin Lymphoma Staging System.
    • 64
    • PDF
    18F-FDG PET and PET/CT in Burkitt's lymphoma.
    • 36